|
| |
| | | 69867 | | 08.07.2025 | | MSD Merck Sharp & Dohme AG | | | | | | | 07.07.2030 | | | | | | 80000. | | | | 08.03. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Prevymis 20 mg | Granulat | Granulat (Letermovirum 20 mg) | J05AX18 | PI | | 02 | Prevymis 120 mg | Granulat | Granulat (Letermovirum 120 mg) | J05AX18 | PI |
|
|
|
